Novel Biologics for the Treatment of Pediatric Severe Asthma

被引：1

作者：

Licari, Amelia ^{[1
,2
]}

Castagnoli, Riccardo ^{[2
]}

Tondina, Enrico ^{[2
]}

Testa, Giorgia ^{[1
]}

Parisi, Giuseppe Fabio ^{[3
]}

Marseglia, Alessia ^{[2
]}

Brambilla, Ilaria ^{[1
,2
]}

Marseglia, Gian Luigi ^{[1
,2
]}

机构：

[1] Fdn IRCCS Policlin San Matteo, SC Pediat, Pavia, Italy

[2] Univ Pavia, Dept Pediat, Pavia, Italy

[3] Univ Catania, Dept Clin & Expt Med, Catania, Italy

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2019年 / 15卷 / 03期

关键词：

Benralizumab; children; dupilumab; mepolizumab; omalizumab; reslizumab; severe asthma; SEVERE EOSINOPHILIC ASTHMA; SEVERE ALLERGIC-ASTHMA; ANTI-IGE; IMMUNOGLOBULIN-E; DOUBLE-BLIND; AIRWAY INFLAMMATION; MONOCLONAL-ANTIBODY; QGE031; LIGELIZUMAB; RANDOMIZED-TRIAL; SERUM IGE;

D O I：

10.2174/1573398X15666190521111816

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Estimated to represent less than 5% of all asthmatic patients, children with severe asthma experience troublesome persistent symptoms, life-threatening attacks and side effects by oral corticosteroid treatment, that significantly impact on the quality of life and on economic costs. An accurate understanding of the mechanisms of the disease has been crucial for the discovery and development of biological therapies, for which children with severe asthma are candidates. The aim of this review is to discuss the use of approved biologics for severe asthma, providing updated evidence of novel targeted therapies in the pediatric age range.

引用

页码：195 / 204

页数：10

共 50 条

[1] Biologics in the treatment of severe asthma
Quirce, S.
Phillips-Angles, E.
Dominguez-Ortega, J.
Barranco, P.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2017, 45 : 45 - 49
[2] The treatment of severe uncontrolled asthma using biologics
Kodaka, Norio
Nakano, Chihiro
Oshio, Takeshi
Matsuse, Hiroto
AIMS ALLERGY AND IMMUNOLOGY, 2020, 4 (01): : 1 - 13
[3] A summary of novel biologics for asthma treatment
Drygala, Roxana
Waszczykowska, Klaudia
Wegierska, Marta
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (02) : 98 - 105
[4] Biologics in severe asthma
Pelaia, Corrado
Pelaia, Giulia
Crimi, Claudia
Longhini, Federico
Lombardo, Nicola
Savino, Rocco
Sciacqua, Angela
Vatrella, Alessandro
MINERVA MEDICA, 2022, 113 (01) : 51 - 62
[5] Type 2 severe asthma: pathophysiology and treatment with biologics
Pelaia, Corrado
Melhorn, James
Hinks, Timothy S. C.
Couillard, Simon
Vatrella, Alessandro
Pelaia, Girolamo
Pavord, Ian D.
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024, 18 (07) : 485 - 498
[6] Stratified medicine in selecting biologics for the treatment of severe asthma
Morjaria, Jaymin B.
Proiti, Maria
Polosa, Riccardo
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (01) : 58 - 63
[7] Treatment for Severe Asthma in Children: What About Biologics?
Pansare, Milind
Seth, Divya
Kamat, Deepak
Poowuttikul, Pavadee
PEDIATRIC ANNALS, 2021, 50 (05): : E206 - E213
[8] Biologics for severe asthma and beyond
Muemmler, Carlo
Milger, Katrin
PHARMACOLOGY & THERAPEUTICS, 2023, 252
[9] Biologics in severe childhood asthma
Amat, F.
REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (08) : 675 - 683
[10] Emerging Biologics in Severe Asthma
Pavord, Ian D.
Hilvering, Bart
Shrimanker, Rahul
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (03) : 609 - +

← 1 2 3 4 5 →